Could weight-loss drugs hit restaurant sales? UBS weighs in.
NeutralFinancial Markets
UBS has released a report discussing the potential impact of weight-loss drugs on restaurant sales. As these medications gain popularity, there is concern that they could lead to decreased dining out as people focus on weight management. This is significant for the restaurant industry, which has already faced challenges during the pandemic, and it raises questions about how consumer behavior might shift in the coming years.
— Curated by the World Pulse Now AI Editorial System